Pharmacokinetics and Safety/Tolerability Profiles of DA-5206 Versus Talion® Under Fasting and Fed States in Healthy Male Subjects

NCT03200496 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: DA-5206(Fasting)
DRUG: DA-5206(Fed)
DRUG: TALION®

Sponsor

Dong-A ST Co., Ltd.